CHARLOTTESVILLE, VA — The University of Virginia Health System (U.Va. Health) faces a significant leadership shake-up as two of its top executives, Dr. Melina Kibbe and Wendy Horton, quietly exit for prominent roles at other academic institutions. Their departures—confirmed only after media inquiries and absent any formal public announcement—leave U.Va. Health with interim leaders in nearly all major executive roles just as the institution navigates a turbulent period marked by leadership controversies and strategic challenges.

Leadership Departures: Kibbe and Horton Move to National Stage

Dr. Melina Kibbe, who has served as dean of the U.Va. School of Medicine and chief health affairs officer since 2021, is set to become president of the University of Texas Health Science Center at Houston (UTHealth Houston). The UT System Regents announced her as the sole finalist on July 14, in accordance with Texas law, making her appointment effectively confirmed pending a mandatory waiting period. Kibbe, a vascular surgeon and acclaimed academic leader, was tasked during her tenure with advancing U.Va. Health’s 10-year strategic plan, including ambitious goals to enhance research, clinical operations, and reputation as a leading public academic health system.

Simultaneously, Wendy Horton, CEO of the U.Va. Medical Center since 2020, will depart in September to join the leadership team at University of California San Francisco (UCSF) Health, another top-tier academic medical center consistently ranked among the nation’s best by U.S. News & World Report. Horton’s tenure at U.Va. saw significant growth and operational innovations, including efforts to bolster clinical care, community outreach, and pandemic response. UCSF Health, like U.Va., is under pressure to navigate the rapidly changing healthcare landscape and faces its own national challenges.

Institutional Backdrop: Culture Controversies and Faculty Dissent

The high-profile exits come amid a backdrop of internal unrest at U.Va. Health. Last autumn, 128 members of the U.Va. Physicians Group, representing a substantial voice within the faculty, signed a public letter of no confidence in Dr. Kibbe and the former CEO, Dr. Craig Kent. Faculty cited concerns over leadership style, including allegations of fostering a ‘culture of fear and retaliation,’ as well as dissatisfaction with the pace and transparency of decision-making as U.Va. Health executed a major institutional transformation.

In response, the University’s Board of Visitors engaged external legal counsel from Washington, D.C. firm Williams and Connolly to investigate the claims. Though the results of the review were presented in closed session to the Board, public access to the findings was denied, citing legal and personnel confidentiality protections. The investigation’s conclusion led to Dr. Kent’s immediate resignation in February 2025. Dr. Kibbe’s own departure now completes this sweep at the top of U.Va. Health’s hierarchy.

Leadership Vacuum: Interim Executives in Crucial Roles

With Kent and Kibbe gone, U.Va. enters the 2025-2026 academic year with interim appointees in nearly every top leadership position: University President (following Jim Ryan’s resignation), Provost, Chief Executive of U.Va. Health, CEO of the University Medical Center, and Dean of the School of Medicine. This concentration of interim appointments is highly unusual among leading U.S. academic health systems and universities, and raises concerns about continuity, long-term planning, and the institution’s ability to retain and recruit top talent amid ongoing instability.

In a statement, Dr. Mitchell Rosner, Interim CEO of U.Va. Health, praised Kibbe for her contributions in “crafting and advancing U.Va. Health’s strategic plan and expanding our biomedical research enterprise.” Regarding Horton, Rosner credited her as “an enormous driver of growth” and wished her success in her new post at UCSF Health.

Silent Departures: Communication Concerns and Stakeholder Impact

The lack of a formal, proactive announcement regarding the departures has drawn criticism from some corners of the academic and healthcare communities. Best practices in university governance typically call for transparent communication regarding high-level personnel changes, both to maintain confidence among medical staff, faculty, patients, and donors, and to reinforce institutional stability. By confirming the resignations only after outside inquiry, U.Va. Health left many faculty, staff, students, and community stakeholders surprised by the sudden transition.

Leadership turnover at the top can disrupt ongoing projects, delay strategic initiatives, and trigger uncertainty among employees and external partners. Nationally, academic medical centers are facing unprecedented challenges in the wake of COVID-19, including workforce shortages, Medicaid expansion uncertainty, and heightened public scrutiny of institutional culture. In this climate, swift and transparent leadership transitions are considered critical to both internal morale and external reputation.

What’s Next for U.Va. Health?

With the departure of Kibbe and Horton, U.Va. Health faces both challenge and opportunity. The appointment of permanent executives will be closely watched—for their ability to restore confidence and accelerate the strategic initiatives begun over the past five years. There is also greater scrutiny from faculty and alumni, fueled by the recent wave of resignations, on how the Board of Visitors and interim leaders will chart a stable course.

National data from the Association of American Medical Colleges (AAMC) indicates that turnover among medical school deans and academic health system CEOs has increased by nearly 20% since 2022, reflecting broader trends in the sector. Factors such as pandemic-related stress, political pressures on academic institutions, and evolving demands for transparency have accelerated executive churn across the country. At other peer institutions (including the University of Michigan, Emory, and Stanford), leadership instability has prompted vigorous campus debate about governance models and the attributes needed in the next generation of academic health leaders.

For U.Va. Health, 2025 is shaping up to be a crucial year. Interim leaders, faculty, and the Board face the urgent tasks of restoring morale, maintaining excellence in clinical care and medical education, and recruiting the next cohort of visionary executives to steward the health of both the institution and the communities it serves.